Nanobiotix (NBTX) Treasury Shares (2019 - 2025)
Nanobiotix's (NBTX) quarterly Treasury Shares came in at $265401.9 in Q4 2025, up 8.93% year-on-year from $243639.8 in Q4 2024, and up 202.83% quarter-over-quarter from -$258086.8 in Q2 2025.
Nanobiotix (NBTX) Treasury Shares (2019 - 2025) Analysis & Trends
Nanobiotix's Treasury Shares history runs 7 years deep, the most recent figure standing at $265401.9 for Q4 2025.
- On a quarterly basis, Treasury Shares rose 8.93% year-over-year to $265401.9 in Q4 2025; TTM through Dec 2025 was $265401.9, a 8.93% increase from a year earlier, with the FY2025 full-year figure at $257597.0, up 5.73% from the prior year.
- Treasury Shares rose to $265401.9 in Q4 2025 per NBTX's latest filing, from -$258086.8 in the prior quarter.
- Across five years, Treasury Shares topped out at $265401.9 in Q4 2025 and bottomed at -$258086.8 in Q2 2025.
- The 5-year median for Treasury Shares is -$7224.1 (2021), against an average of -$4417.0.
- Biggest YoY gain for Treasury Shares was 8.93% in 2025; the steepest drop was 5.11% in 2025.
- Year by year, Treasury Shares stood at $231082.1 in 2021, then grew by 0.66% to $232616.4 in 2022, then advanced by 5.46% to $245314.3 in 2023, then fell by 0.68% to $243639.8 in 2024, then rose by 8.93% to $265401.9 in 2025.
- Per Business Quant, the three latest NBTX Treasury Shares figures stand at $265401.9 (Q4 2025), -$258086.8 (Q2 2025), and $243639.8 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 34.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 5.14 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 265,401.92 |
| Dec 31, 2025 | 265,401.92 |
| Jun 30, 2025 | -258,086.81 |
| Jun 30, 2025 | -258,086.81 |
| Dec 31, 2024 | 243,639.75 |
| Dec 31, 2024 | 243,639.75 |
| Jun 30, 2024 | -245,530.37 |
| Jun 30, 2024 | -245,530.37 |
| Dec 31, 2023 | 245,314.30 |
| Dec 31, 2023 | 245,314.30 |
| Jun 30, 2023 | -248,274.76 |
| Jun 30, 2023 | -248,274.76 |
| Dec 31, 2022 | 232,616.40 |
| Dec 31, 2022 | 232,616.40 |
| Jun 30, 2022 | -255,026.55 |
| Jun 30, 2022 | -255,026.55 |
| Dec 31, 2021 | 231,082.13 |
| Dec 31, 2021 | 231,082.13 |
| Jun 30, 2021 | -255,305.54 |
| Jun 30, 2021 | -255,305.54 |